Trials / Completed
CompletedNCT06872151
Evaluation of the Effectiveness of a Topical Medical Device in Wound Healing and Symptom Relief in the Postoperative Period of Open Excisional Hemorrhoidectomy (The Emor Study)
Evaluation of the Effectiveness of a Gel Containing a Propionibacterium Extract in Wound Healing and Symptom Relief, Such as Pain, Itching, and Burning, in the Postoperative Period of Open Excisional Hemorrhoidectomy
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 114 (actual)
- Sponsor
- University of Cagliari · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This multicenter randomized controlled phase IV trial aims to compare the clinical efficacy of a gel containing a Propionibacterium extract and a gel with hyaluronic acid and silver sulfadiazine in the degree of epithelialization of post-operative wounds of open excisional hemorrhoidectomy. The main questions it aims to answer are: * To compare the efficacy of the two medical devices in the degree of epithelialization in the postoperative period of open excisional hemorrhoidectomy, at 0, 10, 20 and 40 days from the beginning of treatment. * To evaluate the effectiveness of these devices in alleviating: pain, itching, burning, and the type of bowel habit Participants will be randomized, at the beginning of the study, to one of the two treatments, and the efficacy of the two medical devices will be evaluated at 0, 10, 20 and 40 days from the start of treatment.
Conditions
- Anus Diseases
- Gastrointestinal Diseases
- Intestinal Diseases
- Cicatrization
- Hemorrhoids
- Hemorrhoids Third Degree
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Gel containing a Propionibacterium extract | Patients will apply 1 ml of gel (equal to one phalanx) twice a day for 20 days, manually at the anal level and in the perianal area. In the morning, after defecation and in the evening before going to bed. |
| DRUG | Hyaluronic acid and silver sulfadiazine | Patients will apply 1ml of gel (equal to a phalanx) twice a day for 20 days, manually at the anal level and in the perianal area. In the morning, after defecation and in the evening before going to bed. |
Timeline
- Start date
- 2025-03-04
- Primary completion
- 2025-03-04
- Completion
- 2025-05-30
- First posted
- 2025-03-12
- Last updated
- 2025-07-02
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT06872151. Inclusion in this directory is not an endorsement.